About Myoscience
Myoscience is a company based in Redwood City (United States) founded in 2005 was acquired by Pacira in March 2019. Myoscience has raised $147.68 million across 9 funding rounds from investors including Pacira, Accuitive Medical Ventures and De Novo Ventures. The company has 687 employees as of December 31, 2021. Myoscience operates in a competitive market with competitors including Saluda Medical, Nalu Medical, Biowave, Neuros Medical and Alpha-Stim, among others.
- Headquarter Redwood City, United States
- Employees 687 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Myoscience
Myoscience has successfully raised a total of $147.68M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $5 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Myoscience
Myoscience has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pacira, Accuitive Medical Ventures and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Comprehensive strategic expertise in healthcare is provided by MEDICIS.
|
Locked | Locked | Locked |
Investor details for Myoscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Myoscience
Investment portfolio details for Myoscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Myoscience
Detailed financials for Myoscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Myoscience Comparisons
Peer comparison for Myoscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Myoscience
Myoscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Saluda Medical, Nalu Medical, Biowave, Neuros Medical and Alpha-Stim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
Neuromodulation devices are developed for pain therapy management.
|
|
| Locked | Locked | Locked |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| Locked | Locked | Locked |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
Detailed competitors of Myoscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Myoscience
Complete news archive for Myoscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myoscience
Myoscience was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Myoscience is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Myoscience is a funded company, having raised a total of $147.68M across 9 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Myoscience is 687.
MyoScience engages in development and commercialization of technology driven dermatological products. Company has a Focused Cold Therapy patented technology delivered by the iovera system. The iovera system is FDA cleared in the United States for use in pain management. In Europe and Canada it is approved for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. Recently, iovera has reached maximum enrollment for two knee pain studies which is a non-systemic, non-narcotic solution to blocking pain for extended period of time.
Myoscience's top competitors include Saluda Medical, Nalu Medical and Neuros Medical.
Myoscience has 7 investors. Key investors include Pacira, Accuitive Medical Ventures, De Novo Ventures, MEDICIS, and Saratoga Ventures.